Published in Thromb Haemost on July 01, 2002
Neither fibrin nor plasminogen activator inhibitor-1 deficiency protects lung function in a mouse model of acute lung injury. Am J Physiol Lung Cell Mol Physiol (2008) 1.62
Bench-to-bedside review: acute respiratory distress syndrome - how neutrophils migrate into the lung. Crit Care (2004) 1.57
Clinical characteristics and outcomes of sepsis-related vs non-sepsis-related ARDS. Chest (2010) 1.43
Novel role of the human alveolar epithelium in regulating intra-alveolar coagulation. Am J Respir Cell Mol Biol (2006) 1.29
The procoagulant potential of environmental particles (PM10). Occup Environ Med (2005) 0.98
Systemic inflammation and disseminated intravascular coagulation in early stage of ALI and ARDS: role of neutrophil and endothelial activation. Inflammation (2004) 0.94
The acute respiratory distress syndrome in catastrophic antiphospholipid syndrome: analysis of a series of 47 patients. Ann Rheum Dis (2005) 0.92
A phase I study evaluating the pharmacokinetics, safety and tolerability of an antibody-based tissue factor antagonist in subjects with acute lung injury or acute respiratory distress syndrome. BMC Pulm Med (2012) 0.91
Systemic versus localized coagulation activation contributing to organ failure in critically ill patients. Semin Immunopathol (2011) 0.87
Differential expression, time course and distribution of four PARs in rats with endotoxin-induced acute lung injury. Inflammation (2006) 0.86
Plasmin enhances cell surface tissue factor activity in mesothelial and endothelial cells. J Thromb Haemost (2008) 0.86
Plasminogen activator inhibitor-1 inhibits factor VIIa bound to tissue factor. J Thromb Haemost (2011) 0.81
Xuebijing injection improves the respiratory function in rabbits with oleic acid-induced acute lung injury by inhibiting IL-6 expression and promoting IL-10 expression at the protein and mRNA levels. Exp Ther Med (2014) 0.80
Nebulized fibrinolytic agents improve pulmonary fibrinolysis but not inflammation in rat models of direct and indirect acute lung injury. PLoS One (2013) 0.79
Early intravenous unfractionated heparin and outcome in acute lung injury and acute respiratory distress syndrome: a retrospective propensity matched cohort study. BMC Pulm Med (2012) 0.79
Diagnostic and prognostic utility of tissue factor for severe sepsis and sepsis-induced acute lung injury. J Transl Med (2015) 0.77
Perioperative Bridging Anticoagulation in Patients with Atrial Fibrillation. N Engl J Med (2015) 10.86
Cardiolipin polyspecific autoreactivity in two broadly neutralizing HIV-1 antibodies. Science (2005) 9.04
A pharmacogenetic versus a clinical algorithm for warfarin dosing. N Engl J Med (2013) 7.09
Dose of prophylactic platelet transfusions and prevention of hemorrhage. N Engl J Med (2010) 5.23
Nitric oxide in the human respiratory cycle. Nat Med (2002) 4.50
Evolution of adverse changes in stored RBCs. Proc Natl Acad Sci U S A (2007) 3.58
Effect of escitalopram on mental stress-induced myocardial ischemia: results of the REMIT trial. JAMA (2013) 3.48
Clinical practice. Heparin-induced thrombocytopenia. N Engl J Med (2006) 3.11
Comparative effectiveness of warfarin and new oral anticoagulants for the management of atrial fibrillation and venous thromboembolism: a systematic review. Ann Intern Med (2012) 3.04
Effects of red-cell storage duration on patients undergoing cardiac surgery. N Engl J Med (2015) 3.03
Practice recommendations in the diagnosis, management, and prevention of carbon monoxide poisoning. Am J Respir Crit Care Med (2012) 2.81
RNA aptamers as reversible antagonists of coagulation factor IXa. Nature (2002) 2.73
Survival in critical illness is associated with early activation of mitochondrial biogenesis. Am J Respir Crit Care Med (2010) 2.48
Venous thromboembolism: a public health concern. Am J Prev Med (2010) 2.37
Mitochondrial biogenesis restores oxidative metabolism during Staphylococcus aureus sepsis. Am J Respir Crit Care Med (2007) 2.33
Comparison of characteristics from White- and Black-Americans with venous thromboembolism: a cross-sectional study. Am J Hematol (2010) 2.26
Comparative effectiveness of new oral anticoagulants and standard thromboprophylaxis in patients having total hip or knee replacement: a systematic review. Ann Intern Med (2013) 2.15
The CO/HO system reverses inhibition of mitochondrial biogenesis and prevents murine doxorubicin cardiomyopathy. J Clin Invest (2007) 1.98
Activation of mitochondrial biogenesis by heme oxygenase-1-mediated NF-E2-related factor-2 induction rescues mice from lethal Staphylococcus aureus sepsis. Am J Respir Crit Care Med (2012) 1.85
Guidance on the emergent reversal of oral thrombin and factor Xa inhibitors. Am J Hematol (2012) 1.85
Lipopolysaccharide induces oxidative cardiac mitochondrial damage and biogenesis. Cardiovasc Res (2004) 1.80
Toll-like receptor 4 mediates mitochondrial DNA damage and biogenic responses after heat-inactivated E. coli. FASEB J (2005) 1.72
A nitric oxide processing defect of red blood cells created by hypoxia: deficiency of S-nitrosohemoglobin in pulmonary hypertension. Proc Natl Acad Sci U S A (2005) 1.67
A new activating role for CO in cardiac mitochondrial biogenesis. J Cell Sci (2006) 1.64
Anti-heparin/platelet factor 4 antibody optical density values and the confirmatory procedure in the diagnosis of heparin-induced thrombocytopenia. Thromb Haemost (2008) 1.61
Aspirin exposure reveals novel genes associated with platelet function and cardiovascular events. J Am Coll Cardiol (2013) 1.61
Transient hypoxia stimulates mitochondrial biogenesis in brain subcortex by a neuronal nitric oxide synthase-dependent mechanism. J Neurosci (2008) 1.58
Validation of the high-dose heparin confirmatory step for the diagnosis of heparin-induced thrombocytopenia. Blood (2010) 1.55
Plasmapheresis and heparin reexposure as a management strategy for cardiac surgical patients with heparin-induced thrombocytopenia. Anesth Analg (2009) 1.49
Impact of venous thromboembolism and anticoagulation on cancer and cancer survival. J Clin Oncol (2009) 1.45
How do red blood cells dilate blood vessels? Circ Res (2004) 1.44
Hyperoxia-induced tissue hypoxia: a danger? Anesthesiology (2007) 1.44
Oxalate deposition on asbestos bodies. Hum Pathol (2003) 1.42
Lipopolysaccharide stimulates mitochondrial biogenesis via activation of nuclear respiratory factor-1. J Biol Chem (2003) 1.42
Randomized trial of physician alerts for thromboprophylaxis after discharge. Am J Med (2013) 1.39
Postlipopolysaccharide oxidative damage of mitochondrial DNA. Am J Respir Crit Care Med (2002) 1.38
Blockade of tissue factor: treatment for organ injury in established sepsis. Am J Respir Crit Care Med (2003) 1.38
Hedgehog controls hepatic stellate cell fate by regulating metabolism. Gastroenterology (2012) 1.36
Assays for measuring rivaroxaban: their suitability and limitations. Ther Drug Monit (2010) 1.36
Prevalence and clinical characteristics of mental stress-induced myocardial ischemia in patients with coronary heart disease. J Am Coll Cardiol (2013) 1.34
Extracellular superoxide dismutase. Int J Biochem Cell Biol (2005) 1.34
Blockade of tissue factor-factor X binding attenuates sepsis-induced respiratory and renal failure. Am J Physiol Lung Cell Mol Physiol (2005) 1.31
Hemoglobin, nitric oxide and molecular mechanisms of hypoxic vasodilation. Trends Mol Med (2009) 1.29
Extrinsic coagulation blockade attenuates lung injury and proinflammatory cytokine release after intratracheal lipopolysaccharide. Am J Respir Cell Mol Biol (2002) 1.25
Depressive symptoms and mental stress-induced myocardial ischemia in patients with coronary heart disease. Psychosom Med (2013) 1.24
How do red blood cells cause hypoxic vasodilation? The SNO-hemoglobin paradigm. Am J Physiol Heart Circ Physiol (2006) 1.24
High incidence of antibodies to protamine and protamine/heparin complexes in patients undergoing cardiopulmonary bypass. Blood (2013) 1.16
Two faces of nitric oxide: implications for cellular mechanisms of oxygen toxicity. J Appl Physiol (1985) (2008) 1.14
Genetic basis of murine responses to hyperoxia-induced lung injury. Immunogenetics (2006) 1.13
Retracted Gene-expression patterns predict phenotypes of immune-mediated thrombosis. Blood (2005) 1.12
Nrf2 promotes alveolar mitochondrial biogenesis and resolution of lung injury in Staphylococcus aureus pneumonia in mice. Free Radic Biol Med (2012) 1.08
Iron increases expression of iron-export protein MTP1 in lung cells. Am J Physiol Lung Cell Mol Physiol (2002) 1.08
Carbon monoxide, oxidative stress, and mitochondrial permeability pore transition. Free Radic Biol Med (2005) 1.07
Regulation of the brain's vascular responses to oxygen. Circ Res (2002) 1.06
Ticlopidine-, clopidogrel-, and prasugrel-associated thrombotic thrombocytopenic purpura: a 20-year review from the Southern Network on Adverse Reactions (SONAR). Semin Thromb Hemost (2012) 1.06
Detection of antibody-mediated reduction of annexin A5 anticoagulant activity in plasmas of patients with the antiphospholipid syndrome. Blood (2004) 1.06
Clinical and laboratory diagnosis of von Willebrand disease: a synopsis of the 2008 NHLBI/NIH guidelines. Am J Hematol (2009) 1.05
TNF, IFN-gamma, and endotoxin increase expression of DMT1 in bronchial epithelial cells. Am J Physiol Lung Cell Mol Physiol (2005) 1.04
The iron cycle and oxidative stress in the lung. Free Radic Biol Med (2004) 1.04
Hypercoagulable states and antithrombotic strategies in recurrent vascular access site thrombosis. J Vasc Surg (2003) 1.02
Superoxide dismutase-3 promotes full expression of the EPO response to hypoxia. Blood (2004) 1.02
Carbon monoxide actuates O(2)-limited heme degradation in the rat brain. Free Radic Biol Med (2004) 1.02
Erythropoietin activates mitochondrial biogenesis and couples red cell mass to mitochondrial mass in the heart. Circ Res (2010) 1.01
Antihuman factor V antibodies after use of relatively pure bovine thrombin. Ann Thorac Surg (2005) 1.01
Venous thromboembolic disease. J Natl Compr Canc Netw (2013) 1.01
Co-regulation of nuclear respiratory factor-1 by NFkappaB and CREB links LPS-induced inflammation to mitochondrial biogenesis. J Cell Sci (2010) 1.01
Time-dependent changes in non-COX-1-dependent platelet function with daily aspirin therapy. J Thromb Thrombolysis (2012) 1.00
Heparin modifies the immunogenicity of positively charged proteins. Blood (2010) 1.00
Ticlopidine- and clopidogrel-associated thrombotic thrombocytopenic purpura (TTP): review of clinical, laboratory, epidemiological, and pharmacovigilance findings (1989-2008). Kidney Int Suppl (2009) 1.00
Carbon monoxide, skeletal muscle oxidative stress, and mitochondrial biogenesis in humans. Am J Physiol Heart Circ Physiol (2009) 0.99
The kaolin-activated Thrombelastograph predicts bleeding after cardiac surgery. J Cardiothorac Vasc Anesth (2006) 0.98
Venous thromboembolic disease. Clinical practice guidelines in oncology. J Natl Compr Canc Netw (2006) 0.98
Staphylococcus aureus sepsis and mitochondrial accrual of the 8-oxoguanine DNA glycosylase DNA repair enzyme in mice. Am J Respir Crit Care Med (2010) 0.98
Associations of depressive symptoms, trait hostility, and gender with C-reactive protein and interleukin-6 response after emotion recall. Psychosom Med (2010) 0.98
Differential regulation of the PGC family of genes in a mouse model of Staphylococcus aureus sepsis. PLoS One (2010) 0.97
Two mechanistic pathways for thienopyridine-associated thrombotic thrombocytopenic purpura: a report from the SERF-TTP Research Group and the RADAR Project. J Am Coll Cardiol (2007) 0.97
S-nitrosoglutathione inhibits alpha1-adrenergic receptor-mediated vasoconstriction and ligand binding in pulmonary artery. Am J Physiol Lung Cell Mol Physiol (2005) 0.95
Heparin-induced thrombocytopenia. Annu Rev Med (2010) 0.95
Coagulation abnormalities in patients with hip osteonecrosis. Orthop Clin North Am (2004) 0.95
Discordant extracellular superoxide dismutase expression and activity in neonatal hyperoxic lung. Am J Respir Crit Care Med (2004) 0.95
Oxygenated water and athletic performance. JAMA (2003) 0.95
Oxidative stress activates anion exchange protein 2 and AP-1 in airway epithelial cells. Am J Physiol Lung Cell Mol Physiol (2002) 0.95
Similar but not the same: normobaric and hyperbaric pulmonary oxygen toxicity, the role of nitric oxide. Am J Physiol Lung Cell Mol Physiol (2007) 0.94
Iron homeostasis and oxidative stress in idiopathic pulmonary alveolar proteinosis: a case-control study. Respir Res (2008) 0.94
Regulation of mitochondrial biogenesis and its intersection with inflammatory responses. Antioxid Redox Signal (2015) 0.94
Low-molecular-weight heparin for thromboprophylaxis in pregnant women with mechanical heart valves. J Matern Fetal Neonatal Med (2006) 0.93
Venous thromboembolic disease. J Natl Compr Canc Netw (2011) 0.93
Extracellular superoxide dismutase regulates cardiac function and fibrosis. J Mol Cell Cardiol (2009) 0.93
Prenatal hypoxia decreases lung extracellular superoxide dismutase expression and activity. Am J Physiol Lung Cell Mol Physiol (2002) 0.92
SNO-hemoglobin and hypoxic vasodilation. Nat Med (2008) 0.92